We work with innovators of biotech, healthcare, science, sustainability, and advanced technology

Tim Cox 9/20/22 Tim Cox 9/20/22

GenScript and Avectas aim to reduce the cost of non-viral cell engineering

Two biotech leaders have embarked on a research project to streamline manufacturing of non-viral CRISPR gene editing components. Their goal is to improve the editing efficiency and cell viability of non-viral-based cell therapies.

Tim Cox 5/16/22 Tim Cox 5/16/22

GenScript enables new workflows for CRISPR HDR cell therapy development

GenScript’s new GMP-grade GenExact™ single-stranded DNA (ssDNA) and GenWand™ closed-end linear double-stranded DNA (dsDNA) services enable new workflows

Case study: transforming the narrative on PVC production

ZingPR helped Transform Materials, a Florida-based deeptech startup, announce a groundbreaking collaboration with Johnson Matthey that's set to revolutionize the PVC industry. Our strategic media outreach focused on highlighting the partnership's environmental benefits, scalability, and industry-leading expertise.

We work with innovators of biotech, healthcare, science, sustainability, and advanced technology

GenScript and Avectas aim to reduce the cost of non-viral cell engineering

GenScript enables new workflows for CRISPR HDR cell therapy development

ZingPR’s newsmakers